1442452-21-2

Basic information

• Product Name: (2S)-2-(((perfluorophenoxy)(phenoxy)phosphoryl)amino)propionic acid butyl ester
• Synonyms: (2S)-2-(((perfluorophenoxy)(phenoxy)phosphoryl)amino)propionic acid butyl ester
• CAS NO: 1442452-21-2
• Molecular Weight: 467.329
• Mol File: 1442452-21-2.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: (2S)-2-(((perfluorophenoxy)(phenoxy)phosphoryl)amino)propionic acid butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (2S)-2-(((perfluorophenoxy)(phenoxy)phosphoryl)amino)propionic acid butyl ester(1442452-21-2)
• EPA Substance Registry System: (2S)-2-(((perfluorophenoxy)(phenoxy)phosphoryl)amino)propionic acid butyl ester(1442452-21-2)

Safety Data

• Hazardous Substances Data: 1442452-21-2(Hazardous Substances Data)

Upstream product

• 2885-02-1 (S)-butyl 2-aminopropanoate 
• 770-12-7 O-phenyl phosphorodichloridate 
• 771-61-9 2,3,4,5,6-pentafluorophenol 
• 113706-97-1 N-tert-butoxycarbonyl-L-alanine n-butyl ester 
• 338-69-2 D-Alanine 
• 71-36-3 butan-1-ol 
• 73072-94-3 (S)-butyl 2-aminopropanoate tosylate salt 
• 174468-17-8 (S)-alanine n-butyl ester hydrochloride 

Relevant articles and documents

ANTIVIRAL COMPOUNDS

The present disclosure describes 4'-fluoromethyl nucleosides for treating viral infections, including Dengue.

HCV POLYMERASE INHIBITORS

The invention provides compounds of the formula:wherein B is a nucleobase selected from the groups (a) to (d):and the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects.

DIOXOLANE ANALOGUES OF URIDINE FOR THE TREATMENT OF CANCER

The invention provides compounds of formula (I), wherein: R1 is OR11, or NR5R5'; R2 is H or F; R5 is H, C1-C6alkyl, OH, C(=O)R6, O(C=O)R6 or O(C=O)OR6; R5′ is H or C1-C6alkyl; R6 is C1-C6alkyl or C3-C7cycloalkyl; R13 is H, phenyl, pyridyl, benzyl, indolyl or naphthyl wherein the phenyl, pyridyl, benzyl, indolyl and naphthyl is optionally substituted with 1, 2 or 3 R22; and the other variables are as defined in the claims, which are of use in the treatment of cancer, and related aspects.